Previous close | 2.5186 |
Open | 0.0000 |
Bid | 0.0000 x N/A |
Ask | 0.0000 x N/A |
Day's range | 0.0000 - 0.0000 |
52-week range | |
Volume | |
Avg. volume | 12,412 |
Market cap | 1.884M |
Beta (5Y monthly) | 1.71 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Heron Therapeutics (HRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
With the business potentially at an important milestone, we thought we'd take a closer look at Heron Therapeutics...
Heron Therapeutics ( NASDAQ:HRTX ) Full Year 2023 Results Key Financial Results Revenue: US$127.0m (up 18% from FY...